Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
Plos One|May 17, 2011
HSV neutralization by the microbicidal candidate C5ALot de Witte, Michael D Bobardt, Udayan Chatterji, et al.Antimicrobial Agents and Chemotherapy|April 2, 2014
The combination of alisporivir plus an NS5A inhibitor provides additive to synergistic anti-hepatitis C virus activity without detectable cross-resistanceUdayan Chatterji, Jose A Garcia-Rivera, James Baugh, et al.Journal of Virology|May 28, 2004
Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasionMichael D Bobardt, Patrick Salmon, Lianchun Wang, et al.The Journal of Biological Chemistry|July 18, 2012
Correlation between NS5A dimerization and hepatitis C virus replicationPrecious J Lim, Udayan Chatterji, Daniel Cordek, et al.Proceedings of the National Academy of Sciences of the United States of America|April 2, 2008
Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virusMichael D Bobardt, Guofeng Cheng, Lot de Witte, et al.The Journal of Biological Chemistry|September 15, 2005
A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifsAymeric de Parseval, Michael D Bobardt, Anju Chatterji, et al.Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitroGuofeng Cheng, Ana Montero, Pablo Gastaminza, et al.Journal of Hepatology|May 11, 2010
HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitorsUdayan Chatterji, Precious Lim, Michael D Bobardt, et al.Antiviral Research|June 29, 2021
A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agentsThuc Nguyen Dan Do, Kim Donckers, Laura Vangeel, et al.Pharmaceutical Research|November 23, 2022
Preclinical Considerations for Long-acting Delivery of Tenofovir Alafenamide from Subdermal Implants for HIV Pre-exposure ProphylaxisManjula Gunawardana, Mariana Remedios-Chan, Debbie Sanchez, et al.Pageof 6